Phase II study of a combination of CPT-11, 5FU/l-LV and UFT/LV in patients with advanced/recurrent colorectal cancer
Phase 2
- Conditions
- advanced/recurrent colorectal cancer
- Registration Number
- JPRN-UMIN000000613
- Lead Sponsor
- Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)interstitial pneumonitis or pulmonary fibrosis 2)with cavity fluid to be treated 3)with present active double cancer or D.B. diagnosed less than 5 years before, excluding cured cancer in situ or skin cancer 4)ileus 5)watery diarrhea 6)D.M. which needs insulin or uncontrolled D.M. 7)With other diseases which influence to the study (heart diseases, liver dysfunction, renal failure) 8)brain metastasis with some symptoms 9)pregnant women or suspected women 10)receiving atazanavir sulfate 11)Receiving steroids treatment 12)With experience of drug anaphylaxis shock 13)Doctor stop due to miscellaneous factors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method